Edit search
Cancer patients treated with sunitinib or sorafenib have suf…
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination
Article, Chapter
Authors: S.F. Mulder
Publication: Volume:17, Page(s):4541
Published: 2011
Browse related articles
  Request a copy of this item
Cite this item